Details for Patent: 9,867,810

Which drugs does patent 9,867,810 protect, and when does it expire?

Patent 9,867,810 protects QLOSI and is included in one NDA.

This patent has twenty-three patent family members in fourteen countries.

Summary for Patent: 9,867,810

Title:	Ophthalmic pharmaceutical compositions and uses relating thereto
Abstract:	The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
Inventor(s):	Feinbaum Claes, Salamun Franc, Patel Sudhir
Assignee:	Orasis Pharmaceuticals Ltd.
Application Number:	US15680967
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 9,867,810

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes			Y			TREATMENT OF PRESBYOPIA

International Family Members for US Patent 9,867,810

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017311636
Australia	2023226732
Brazil	112019002967
Canada	3031370
China	109803652